Response to mechanism of action of APOL1 in renal allograft survival (and native CKD) remains unclear

American Journal of Transplantation

Volumn 11, Issue 10, 2011, Pages 2260-

  Reeves Daniel, A M ^a   Divers, J ^a   Langefeld, C D ^a   Freedman, B I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN APOL1; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELE; CADAVER KIDNEY; EUROPEAN AMERICAN; GENE FREQUENCY; GENETIC RISK; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; LETTER; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 80053319756     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03672.x     Document Type: Letter

References (6)

1. Johnstone DB,. Mechanism of action of APOL1 in renal allograft survival (and native CKD) remains unclear (Letter). Am J Transplant 2011; in press.
2. Reeves-Daniel AM, DePalma JA, Bleyer AJ, et al,. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025-1030.
3. Genovese G, Friedman DJ, Ross MD, et al,. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
4. Freedman BI, Kopp JB, Langefeld CD, et al,. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426.
5. O'Seaghdha CM, Parekh RS, Hwang SJ, et al,. The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet 2011; 20: 2450-2456.
6. Reeves-Daniel A, Bailey A, Assimos D, et al,. Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant 2011. doi:.